Core Viewpoint - HOME CONTROL (01747.HK) has entered into a placement agreement with Macquarie to issue up to 28.424 million shares at a price of HKD 3.80 per share, representing a discount of approximately 18.98% from the last closing price of HKD 4.69 on November 17 [1][2] Group 1 - The total number of shares to be placed is equivalent to about 5.61% of the company's existing issued share capital as of the announcement date [1] - The estimated total proceeds from the placement are approximately HKD 108 million, with a net amount expected to be around HKD 106.3 million [2] Group 2 - Approximately 70% of the net proceeds will be allocated to research and development activities related to the group's healthcare business, including AIoT technology and core personal healthcare management products [2] - About 20% of the net proceeds will support the implementation and operation of the healthcare-related business, such as industry research, business analysis, compliance management, and seeking strategic partnerships [2] - The remaining 10% of the net proceeds will be used to supplement working capital and for general corporate purposes [2]
HOME CONTROL(01747.HK)拟配售最多2842.4万股 总筹1.08亿港元